GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Price-to-Operating-Cash-Flow

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2024)


View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Price-to-Operating-Cash-Flow?

As of today (2024-06-03), TC BioPharm (Holdings)'s share price is $1.0699. TC BioPharm (Holdings)'s Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-20.71. Hence, TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow or its related term are showing as below:

TCBP's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.2
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

TC BioPharm (Holdings)'s Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-2.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-20.71.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 33.60% per year.

During the past 5 years, TC BioPharm (Holdings)'s highest 3-Year average Operating Cash Flow per Share Growth Rate was 33.60% per year. The lowest was -22.20% per year. And the median was 5.70% per year.


TC BioPharm (Holdings) Price-to-Operating-Cash-Flow Historical Data

The historical data trend for TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Price-to-Operating-Cash-Flow Chart

TC BioPharm (Holdings) Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - - -

TC BioPharm (Holdings) Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow falls into.



TC BioPharm (Holdings) Price-to-Operating-Cash-Flow Calculation

TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.0699/-20.714
=

TC BioPharm (Holdings)'s Share Price of today is $1.0699.
TC BioPharm (Holdings)'s Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.71.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

TC BioPharm (Holdings) Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Traded in Other Exchanges
Address
Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
Executives
Renaissance Capital Partners Ltd 10 percent owner 42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD